13 studies found for:    hong proton | Open Studies | Exclude Unknown
Show Display Options
Rank Status Study
1 Recruiting PPI for Prevention of Post-sphincterotomy Bleeding
Conditions: Bleeding;   ERCP
Interventions: Drug: Esomeprazole;   Other: Standard care
2 Recruiting Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: FOLFIRINOX;   Drug: Losartan;   Radiation: Proton Beam Radiation
3 Recruiting H2RA VS PPI for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk
Condition: Peptic Ulcer Bleeding
Interventions: Drug: Rabeprazole;   Drug: Famotidine
4 Recruiting Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Capecitabine;   Drug: Hydroxychloroquine;   Radiation: Proton or Photon Radiation Therapy
5 Recruiting PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
Condition: Peptic Ulcer
Interventions: Drug: Lansoprazole;   Drug: Famotidine
6 Not yet recruiting Translation and Validation of the PASS Test for GERD Patients With Partial Response to PPI in Chinese Population: PASS-C
Condition: Gastro-esophageal Reflux Disease
7 Recruiting BRAVO Study for Functional Dyspepsia
Conditions: Dyspepsia;   Gastroesophageal Reflux
Interventions: Drug: Esomeprazole 20mg;   Other: Placebo
8 Recruiting Second-look Endoscopy in High Risk Patients After Endoscopic Hemostasis to Their Bleeding Peptic Ulcers Improves Their Outcomes
Condition: Ulcer Bleeding
Interventions: Procedure: epinephrine injection or heater probe or hemoclips;   Other: Observation only
9 Recruiting FOLFIRINOX + RT for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: FOLFIRINOX;   Drug: Capecitabine;   Radiation: Short Course Radiation;   Procedure: Surgery
10 Not yet recruiting Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease
Conditions: Obstructive Sleep Apnea;   Non-alcoholic Fatty Liver Disease
Intervention: Device: Continuous positive airway pressure (CPAP)
11 Recruiting Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment
Condition: Helicobacter Pylori Infection
Interventions: Drug: Esomeprazole;   Drug: Bismuth Potassium Citrate;   Drug: Clarithromycin;   Drug: Amoxicillin;   Drug: Metronidazole
12 Recruiting A Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product
Condition: Healthy Adult Subjects
Interventions: Drug: Nexium powder for injection and infusion 40 mg;   Drug: Esomelone Powder for Solution for Injection / Infusion 40 mg
13 Recruiting S-pantoprazole 10mg Phase III Clinical Study
Condition: Non Erosive Reflux Disease
Interventions: Drug: S-pantoprazole 10mg;   Drug: Placebo

Indicates status has not been verified in more than two years